SCHEMBL7958772

SCHEMBL7958772

CCOc1cc2c(cc1OCC)C1CCCCC1N=C2c1ccc(C(=O)OC)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 5/20 0.56
PDE4A P27815 4/20 0.56
PDE4B Q07343 4/20 0.56
PDE4C Q08493 4/20 0.56
S1PR1 P21453 1/20 0.37
APOBEC3G Q9HC16 2/20 0.36
EGFR P00533 1/20 0.36
ALDH1A1 P00352 2/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.35
ALPL P05186 1/20 0.35
ALPI P09923 1/20 0.35
ALPG P10696 1/20 0.35
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206484 1.00 PDE4D (0.56) PDE4DPDE4APDE4BPDE4CS1PR1
SCHEMBL7206486 1.00 PDE4D (0.56) PDE4DPDE4APDE4BPDE4CS1PR1
SCHEMBL7400096 0.90 PDE4D (0.50) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL5057946 0.90 PDE4D (0.50) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL7205164 0.90 PDE4D (0.50) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL5056368 0.90 PDE4D (0.50) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL7960396 0.89 PDE4D (0.47) PDE4DPDE4APDE4BPDE4CS1PR1
SCHEMBL2882721 0.86 PDE4D (0.58) PDE4DPDE4APDE4BPDE4CSMN1; SMN2
SCHEMBL13350269 0.86 PDE4D (0.75) PDE4DPDE4APDE4BPDE4CS1PR1
SCHEMBL2882717 0.86 PDE4D (0.58) PDE4DPDE4APDE4BPDE4CSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1849468-A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist Nycomed GmbH (DE) 2007-10-31 EP disclosed
WO-2004047817-A1 PDE4 AND PDE3/4 INHIBITORS FOR USE IN THE TREATMENT OF CACHEXIA ALTANA PHARMA AG (DE) 2004-06-10 WO disclosed
WO-2003024488-A2 COMBINATION OF A PDE INHIBITOR AND A LEUKOTRIENE RECEPTOR ANTAGONIST ALTANA PHARMA AG (DE) 2003-03-27 WO disclosed
US-6191138-B1 THERAPY FOR RESPIRATORY SYSTEM DISORDERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2001-02-20 US disclosed